Concepedia

Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine

Mauro Bafutto, José Roberto de Almeida, Naylé V. Leite, Ênio Chaves de Oliveira, Salustiano Gabriel-Neto, Joffre Rezende-Filho

Arquivos de Gastroenterologia · 2011 · 26 citations · 20 references

DOIFull text

Open access

Abstract

Mesalazine reduced key symptoms of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with diarrhea patients.

References

20

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute <i>Campylobacter</i> enteritis and in post-dysenteric irritable bowel syndrome

Robert E. Spiller · Gut · 2000 · 1.1K citations · Full text

Activation of the mucosal immune system in irritable bowel syndrome

V. S. Chadwick, Wangxue Chen, Dairu Shu et al. · Gastroenterology · 2002 · 825 citations · Full text

, , +10

The role of psychological and biological factors in postinfective gut dysfunction

K-A Gwee, Y-L Leong, Christopher D. Graham et al. · Gut · 1999 · 769 citations · Full text

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.

Claudia Wahl, Susanne Liptay, G. Adler et al. · Journal of Clinical Investigation · 1998 · 734 citations · Full text

, , +20

Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome

K-A Gwee · Gut · 2003 · 414 citations · Full text